systematic_review·obstetrics and gynecology, epidemiology, systematic review, hematology, public health·PMC10034471
High Homocysteine Levels During Pregnancy and Its Association With Placenta-Mediated Complications: A Scoping Review
Cureus · 2 authors, 1 centre
AI SUMMARY
FIDELITY 100%
This summary was generated by AI from a single paper. It has not been reviewed by a clinician and is not clinical advice. Verify against the source before acting on it.
This scoping review of studies from 2010 to 2022 found an association between elevated maternal homocysteine levels in pregnancy and an increased risk of placenta-mediated complications, including preeclampsia, fetal growth restriction, abruption, and early spontaneous abortions.
Full summary
753 CHARS
This scoping review analyzed research papers from 2010 to 2022 to integrate evidence on the association between elevated maternal homocysteine levels in early pregnancy and placenta-mediated complications. The review identified that homocysteine levels fluctuate during pregnancy and are influenced by regional, cultural, and socioeconomic factors. The central result is a reported connection between high homocysteine and complications such as preeclampsia, fetal growth restriction, abruption, recurrent pregnancy losses, and maternal/newborn death. The authors note that further research is needed to identify genetic components of homocysteine metabolism abnormalities and to determine optimal timing for testing to enable preventative intervention.